|1.||Rosenfield, Robert L: 4 articles (12/2015 - 06/2002)|
|2.||Azziz, Ricardo: 4 articles (07/2010 - 06/2005)|
|3.||Berghella, Vincenzo: 3 articles (10/2015 - 04/2010)|
|4.||Garite, Thomas J: 3 articles (09/2015 - 01/2011)|
|5.||Das, Anita: 3 articles (09/2015 - 01/2011)|
|6.||Combs, C Andrew: 3 articles (09/2015 - 01/2011)|
|7.||Obstetrix Collaborative Research Network: 3 articles (09/2015 - 01/2011)|
|8.||Maurel, Kimberly: 3 articles (09/2015 - 01/2011)|
|9.||Martin, James N: 3 articles (01/2015 - 09/2009)|
|10.||Veillon, Edward W: 3 articles (01/2011 - 09/2009)|
06/01/1999 - "One of her siblings, a 16-year old girl, was also diagnosed of mild hirsutism and increased levels of basal and post-stimulation 17-hydroxyprogesterone. "
06/01/1999 - "The index case in the first family had a mild hirsutism which appeared peripuberally and basal 17-hydroxyprogesterone over the measurement limit. "
06/01/1979 - "The polycystic ovary: hirsutism and 17 alpha-hydroxyprogesterone."
07/01/2010 - "Nonclassic adrenal hyperplasia should be excluded in all women presenting with hirsutism, with use of a basal follicular phase 17-hydroxyprogesterone level, regardless of the presence of polycystic ovaries or metabolic dysfunction; however, women with nonclassic adrenal hyperplasia have a higher prevalence of normal ovulation and lower likelihood of having an LH/FSH ratio >2 or polycystic ovaries."
02/12/1994 - "[Evaluation of salivary 17-hydroxyprogesterone and its clinical usefulness in the study of hirsutism and the partial deficiency of 21-hydroxylase]."
|2.||Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal)
11/01/2012 - "Patients with congenital adrenal hyperplasia had significantly greater levels of basal and peak 17-hydroxyprogesterone than those with isolated premature adrenarche (p < 0.001). "
01/01/2014 - "Newborn screening for congenital adrenal hyperplasia (CAH) based on measuring 17-hydroxyprogesterone (17-OHP) by immunoassay generates a number of false-positive results, especially in preterm neonates. "
01/01/1997 - "Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels."
11/01/2014 - "(1) Thirty-four patients were diagnosed with nonclassical-congenital adrenal hyperplasia (NC-CAH) based on the 17-hydroxyprogesterone (17-OHP) levels and the presence of two mutations in CYP21A2 and therefore were excluded from the study, 66 were found to be heterozygotes and finally 105 had no identifiable mutations. "
01/01/2008 - "This study investigated the use of corrected 17-alpha-hydroxyprogesterone (17-OHP) values to detect congenital adrenal hyperplasia (CAH) in newborn infants. "
05/01/1998 - "hCG stimulation elicited greater 17-hydroxyprogesterone responses in adolescent girls with functional ovarian hyperandrogenism compared with healthy controls. "
07/01/1997 - "Therefore, the 17-hydroxyprogesterone response to HCG could represent a useful test for the diagnosis of ovarian hyperandrogenism. "
02/01/1990 - "On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism."
07/01/1997 - "Study subjects were normal women (n = 13); women with functional ovarian hyperandrogenism, defined by androgen excess, amenorrhoea and an increased 17-hydroxyprogesterone response to nafarelin (n = 6); and normal men (n = 4). "
12/01/1994 - "Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism."
03/01/1993 - "Three women of two families (2.3%) had a 17-hydroxyprogesterone response consistent with 21-hydroxylase-deficient late-onset adrenal hyperplasia and were excluded from further study. "
07/01/2010 - "Basal 17-hydroxyprogesterone levels >2 ng/mL were found in 87%, 25%, 20%, and 7% of women with nonclassic adrenal hyperplasia, lean women with PCOS, obese women with PCOS, and controls, respectively. "
11/01/1999 - "To prospectively establish the specificity, sensitivity, and positive predictive value (PPV) of a basal 17-hydroxyprogesterone (17-HP) level for the screening of 21-hydroxylase-deficient nonclassic adrenal hyperplasia (NCAH) among hyperandrogenic women. "
02/01/1986 - "Thus HLA typing and hormonal data, particularly 17-hydroxyprogesterone, are useful, also in this form of congenital hyperplasia, in detecting heterozygotes."
01/01/1980 - "Normal values for infants, children, and adults have been established, and the individual concentrations of 17 alpha-hydroxyprogesterone in the serum of patients withcongenital adrenal hyperplasia were well separated from normal values."
|5.||Premature Obstetric Labor (Premature Labor)
10/01/2008 - "The objective of the study was to compare pregnancy outcomes of women receiving 17-alpha-hydroxyprogesterone caproate (17P) prophylaxis for the prevention of recurrent spontaneous preterm delivery (SPTD) hospitalized for preterm labor (PTL) less than 34 weeks' gestation prescribed daily vs weekly perinatal nursing surveillance. "
10/01/2008 - "Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance."
02/01/2008 - "Withdrawal of 17 alpha-hydroxyprogesterone: a possible trigger for preterm labor?"
07/30/1958 - "Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage."
07/01/2015 - "We sought to evaluate the efficacy of maintenance tocolysis with 17-alpha-hydroxyprogesterone caproate (17P) compared to control (either placebo or no treatment) in singleton gestations with arrested preterm labor (PTL), in a metaanalysis of randomized trials. "
|3.||Androstenedione (4 Androstene 3,17 dione)
|6.||Gonadotropin-Releasing Hormone (GnRH)
|9.||Adrenocorticotropic Hormone (ACTH)
|10.||Steroid 21-Hydroxylase (21 Hydroxylase)